Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Organon & Co. (OGN) and Encourages Investors to Learn More About the Investigation — Neutral
OGN Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Organon & Co. ("Organon" or "the Company") (NYSE: OGN). Investors who purchased Organon securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OGN.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cable One, Inc. (CABO) And Encourages Stockholders to Connect — Neutral
CABO Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cable One, Inc. ("Cable One" or "the Company") (NYSE:CABO). Investors who purchased Cable One securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CABO.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Kohl's Corporation (KSS) And Encourages Investors to Connect — Neutral
KSS Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kohl's Corporation ("Kohl's" or "the Company") (NYSE:KSS). Investors who purchased Kohl's securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/KSS.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Amerant Bancorp Inc. (AMTB) And Encourages Stockholders to Connect — Neutral
AMTB Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. ("Amerant" or "the Company") (NYSE:AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AMTB.

Bronstein, Gewirtz & Grossman, LLC Is Investigating PTC Therapeutics, Inc. (PTCT) And Encourages Investors to Connect — Neutral
PTCT Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.

Affirm's Inflection Is Here - Possible Near Doubling Upside — Positive
AFRM Seeking Alpha — May 12, 2025AFRM's focus on 0% APR offerings have already triggered improved consumer acquisition trends and healthier risk profile, during an uncertain macro environment. The BNPL company has also reached an improved operating scale, as observed in its positive profit margins and raised FY2025 guidance. While AFRM may appear to be trading at a notable premium at current levels, the stock continues to offer rich double digits upside potential, if not, near doubling.

Bronstein, Gewirtz & Grossman, LLC Encourages SelectQuote, Inc. (SLQT) Stockholders to Inquire about Securities Investigation — Neutral
SLQT Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE:SLQT). Investors who purchased SelectQuote securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SLQT.

Cytokinetics, Incorporated (CYTK) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation — Neutral
CYTK Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cytokinetics, Incorporated ("Cytokinetics" or "the Company") (NASDAQ:CYTK). Investors who purchased Cytokinetics securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/CYTK.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Investors to Learn More About the Investigation — Neutral
ARVN Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. ("Arvinas" or "the Company") (NASDAQ:ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ARVN.

FTI Consulting, Inc. (FCN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
FCN Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of FTI Consulting, Inc. ("FTI" or "the Company") (NYSE: FCN). Investors who purchased FTI securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/FCN.

Bronstein, Gewirtz & Grossman, LLC Encourages T-Mobile US, Inc. (TMUS) Shareholders to Inquire about Securities Investigation — Neutral
TMUS Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of T-Mobile US, Inc. ("T-Mobile" or "the Company") (NASDAQ:TMUS). Investors who purchased T-Mobile securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TMUS.

Bronstein, Gewirtz & Grossman, LLC Encourages Wabash National Corporation (WNC) Stockholders to Inquire about Securities Investigation — Neutral
WNC Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wabash National Corporation ("Wabash" or "the Company") (NYSE:WNC). Investors who purchased Wabash securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/WNC.

Bronstein, Gewirtz & Grossman, LLC Encourages Landstar System, Inc. (LSTR) Shareholders to Inquire about Securities Investigation — Neutral
LSTR Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Landstar System, Inc. ("Landstar" or "the Company") (NASDAQ:LSTR). Investors who purchased Landstar securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/LSTR.

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect — Neutral
TFX Accesswire — May 12, 2025NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX.

Exact Sciences Earns 2025 Great Place To Work® Certification™ — Neutral
EXAS Business Wire — May 12, 2025MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today that it has been certified as a 2025 Great Place To Work® for the seventh consecutive year in the U.S., and for the first time in the U.K., Japan, Canada, France, Italy, Poland, and Germany. The recognition is based on a confidential survey of employees around the world, offering an independent assessment of Exact Sciences' culture, work environment, and le.

D-Wave Quantum Inc. (QBTS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation — Neutral
QBTS Accesswire — May 12, 2025NEW YORK, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of D-Wave Quantum Inc. ("D-Wave" or "the Company") (NYSE:QBTS). Investors who purchased D-Wave securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QBTS.

AmpliTech Group Achieves FCC Certification For Its 5G ORAN Low Power Radios For Private 5G Deployments In US — Neutral
AMPG AMPGW GlobeNewsWire — May 12, 2025HAUPPAUGE, N.Y., May 12, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today proudly announces a significant milestone: the FCC Certification of its cutting-edge ORAN LPRU-Gen3-3537-AE-AI 5G radios.

Corporate Bonds Look Appealing Amid Tariff Pause — Positive
VCIT VCLT VCSH ETF Trends — May 12, 2025There's still a lot of uncertainty in the bond markets, especially the corporate variety. But with tariff negotiations underway, especially with China, the pause could present investors with an opportune time to snatch up corporate bonds.

LPRO Investors Have Opportunity to Lead Open Lending Corporation Securities Fraud Lawsuit with the Schall Law Firm — Neutral
LPRO PRNewsWire — May 12, 2025LOS ANGELES , May 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Open Lending Corporation ("Open Lending" or "the Company") (NASDAQ: LPRO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 24, 2022 and March 31, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before June 30, 2025.

LSTR Investors Have Opportunity to Join Landstar System, Inc. Fraud Investigation with the Schall Law Firm — Neutral
LSTR PRNewsWire — May 12, 2025LOS ANGELES , May 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Landstar System, Inc. ("Landstar" or "the Company") (NASDAQ: LSTR) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
